Fagotti, Anna
 Distribuzione geografica
Continente #
NA - Nord America 8.282
EU - Europa 7.162
AS - Asia 1.870
AF - Africa 63
SA - Sud America 38
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 11
Totale 17.445
Nazione #
US - Stati Uniti d'America 8.236
SE - Svezia 1.648
DE - Germania 1.612
IT - Italia 1.278
CN - Cina 1.017
IE - Irlanda 598
UA - Ucraina 499
SG - Singapore 444
FR - Francia 357
PL - Polonia 355
RU - Federazione Russa 204
GB - Regno Unito 198
IN - India 164
FI - Finlandia 162
TR - Turchia 77
BE - Belgio 54
CI - Costa d'Avorio 47
CZ - Repubblica Ceca 40
NL - Olanda 39
IR - Iran 35
JP - Giappone 32
CA - Canada 28
HK - Hong Kong 27
AT - Austria 18
CH - Svizzera 18
ES - Italia 17
AU - Australia 16
RO - Romania 15
BR - Brasile 14
BZ - Belize 11
KR - Corea 11
PH - Filippine 10
EU - Europa 9
HR - Croazia 9
CL - Cile 8
OM - Oman 7
EG - Egitto 6
ID - Indonesia 6
MX - Messico 6
PT - Portogallo 6
SA - Arabia Saudita 6
VN - Vietnam 6
HU - Ungheria 5
IL - Israele 5
MY - Malesia 5
AR - Argentina 4
DK - Danimarca 4
GR - Grecia 4
MD - Moldavia 4
PE - Perù 4
BD - Bangladesh 3
BG - Bulgaria 3
EC - Ecuador 3
EE - Estonia 3
LT - Lituania 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
GF - Guiana Francese 2
LA - Repubblica Popolare Democratica del Laos 2
LI - Liechtenstein 2
LK - Sri Lanka 2
MA - Marocco 2
MK - Macedonia 2
NG - Nigeria 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
IQ - Iraq 1
MT - Malta 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 17.445
Città #
Chandler 2.049
Ashburn 747
Dublin 592
San Mateo 402
Warsaw 339
Jacksonville 294
Wilmington 286
Singapore 281
Ann Arbor 256
Rome 241
New York 234
Boston 228
Nanjing 208
Princeton 184
Woodbridge 176
Milan 169
Moscow 164
Houston 163
Beijing 160
Fairfield 158
Marseille 156
Dearborn 147
Cattolica 123
Nürnberg 105
Redwood City 99
Seattle 99
Lawrence 97
Boardman 82
Nanchang 66
Los Angeles 58
Bremen 56
Mountain View 54
Hangzhou 49
Izmir 49
Brussels 48
Abidjan 47
Kunming 47
Norwalk 45
Cambridge 44
Leawood 41
Helsinki 40
Fuzhou 35
Zhengzhou 35
Hebei 34
Shenyang 31
Changsha 30
Redmond 30
Augusta 29
Oggiono 28
University Park 28
Busto Arsizio 27
Detroit 27
Pune 27
Amsterdam 26
Chicago 26
Lancaster 25
Washington 22
Andover 21
Jiaxing 20
Olomouc 20
Falls Church 19
Guangzhou 19
Munich 18
Naples 18
Tianjin 18
Hefei 17
Lappeenranta 17
Shanghai 16
Vienna 16
Edinburgh 15
Fremont 15
San Francisco 15
Ardabil 14
Hong Kong 14
Salò 14
San Jose 14
Brno 13
London 13
Toronto 13
Genazzano 12
Jinan 12
Belize City 11
Clearwater 11
Bari 10
Buffalo 10
Orange 10
Tokyo 10
Changchun 9
Frankfurt am Main 9
Kraków 9
Lanzhou 9
Kish 8
Zagreb 8
Bern 7
Cedar Knolls 7
Costa Mesa 7
Florence 7
Gunzenhausen 7
Indiana 7
Menlo Park 7
Totale 9.889
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 793
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 306
Laparoendoscopic Single-Site Surgery (LESS) for Treatment of Benign Adnexal Disease: Single-Center Experience Over 3-Years 300
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 243
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 232
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. 232
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 164
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 160
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 158
Delaying surgery for patients with a previous SARS-CoV-2 infection 147
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 143
Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery 143
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 143
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 134
Urologic surgery in gynecologic oncology: a large single-institution experience 131
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 128
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 126
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 125
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 123
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 120
The sonographic prediction of invasive carcinoma in unilocular-solid ovarian cysts in premenopausal patients: a pilot study. 119
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 117
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 113
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 109
Importance of a specialized pathologist for the examination of frozen sections of adnexal masses. 109
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 109
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 109
Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience 102
Sexual and reproductive outcomes in early stage cervical cancer patients after excisional cone as a fertility-sparing surgery: An italian experience 102
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 101
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 98
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 97
Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study 97
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 94
The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study 90
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 87
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 84
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 83
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 83
Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers 82
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 81
Excisional cone as fertility-sparing treatment in early-stage cervical cancer. 80
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 79
Targeting the hallmarks of ovarian cancer: The big picture 78
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 77
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 77
Simple conization and lymphadenectomy for the conservative treatment of stage IB1 cervical cancer. An Italian experience 76
TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes 76
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 76
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 75
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 75
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 75
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 74
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 73
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 72
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 72
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer 71
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 71
Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study 70
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 70
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 69
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 69
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 69
Molecular profile of brca-negative long survivor high grade serous ovarian cancer patients using a somatic multigene panel 69
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 68
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 68
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 68
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 67
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 67
Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results 67
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 67
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 67
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 66
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 66
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept 65
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 65
BRCA testing delay during the COVID-19 pandemic: How to act? 65
Is There a Role for Tertiary (TCR) and Quaternary (QCR) Cytoreduction in Recurrent Ovarian Cancer? 64
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 64
Neoadjuvant chemoradiation followed by radical hysterectomy in FIGO Stage IIIB cervical cancer: feasibility, complications, and clinical outcome. 63
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer. 63
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 63
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 62
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 62
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach 62
[Prevention of postoperative abdominal adhesions in gynecological surgery. Consensus paper of an Italian gynecologists' task force on adhesions] 61
Feasibility and Surgical Outcome in Obese Versus Nonobese Patients Undergoing Laparoendoscopic Single-site Hysterectomy: A Multicenter Case-control Study 61
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 61
Additional molecular and clinical evidence open the way to definitive IARC classification of the BRCA1 c.5332G > A (p.Asp1778Asn) variant 60
Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach 60
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 59
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 59
Spliceogenic analysis of BRCA1 c.439T>C (rs794727800) variant by High Resolution Melting Analysis 59
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 59
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival 58
Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL) 58
Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience 58
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 58
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 58
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 58
Totale 10.066
Categoria #
all - tutte 88.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.636


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.673 0 0 95 106 123 214 261 125 213 156 227 153
2020/20211.861 129 161 227 142 232 66 198 50 192 115 296 53
2021/20222.580 170 118 30 257 99 67 96 433 122 153 445 590
2022/20235.649 750 716 452 767 381 731 275 396 692 98 244 147
2023/20243.284 118 886 101 284 101 370 225 124 74 192 353 456
2024/2025287 155 132 0 0 0 0 0 0 0 0 0 0
Totale 18.397